ZimVie is spine and dental and one of the world's leading orthopedic suppliers.
ZimVie is a focused spine and dental company formed through the 2022 spinoff from Zimmer Biomet, with revenues of approximately $450 million in 2025. The company's spine portfolio encompasses interbody fusion devices, motion preservation technologies, bone growth stimulation, and biologics — with particular strength in the Mobi-C cervical disc arthroplasty system and the Tether vertebral body tethering system for pediatric scoliosis. ZimVie's dental implant business provides revenue diversification alongside spine. As an independent company, ZimVie must demonstrate its ability to invest in product development, sales infrastructure, and clinical evidence generation without the balance sheet support of its former Zimmer Biomet parent.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Acquisitions and divestitures
• Marketing tactics
• Financial results
• Strengths and weaknesses
• Strategic directions
Table of Contents
1. Executive Summary
2. Company Overview and Business Model
3. Strategic Directions
4. Financial Results
5. SWOT Analysis
6. Technological Know-How and Key Products
7. Acquisitions and Divestitures
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. ZimVie — Key Financial Metrics 2023-2025
Table 2. ZimVie — Revenue by Segment 2023-2025
Table 3. ZimVie — Revenue by Geography 2023-2025
Table 4. ZimVie — SWOT Analysis
Table 5. ZimVie — Key Products and Platforms 2025
Table 6. ZimVie — M&A Activity 2020-2025
Table 7. ZimVie — Key Management 2025
Table 8. ZimVie — Strategic Priorities 2025-2030
